Recalls / Firms / Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation
6 FDA drug recalls on record — 1 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2023-11-22 | Class I | SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Onl | Ongoing |
| 2022-09-16 | Class II | Neoral | Terminated |
| 2022-05-10 | Class III | Xiidra | Terminated |
| 2022-05-10 | Class III | Xiidra | Terminated |
| 2022-05-10 | Class III | Xiidra (lifitegrast ophthalmic solution) 5%, packaged in a) 60 Single-Use Containers: 12 p | Terminated |
| 2022-05-10 | Class III | Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-u | Terminated |